NCT04762693 is a clinical trial of Hyfe cough tracker in Covid19, sponsored by Clinica Universidad de Navarra, Universidad de Navarra.

Who is sponsoring NCT04762693?

NCT04762693 is sponsored by Clinica Universidad de Navarra, Universidad de Navarra.

What drugs are being tested in NCT04762693?

Interventions in NCT04762693: Hyfe cough tracker.

What condition does NCT04762693 study?

NCT04762693 studies Covid19, Cough.

Is NCT04762693 still recruiting?

NCT04762693 is currently completed. Last updated 20 July 2022.

Last reviewed 2022-07-20 · How we verify

NCT04762693

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Digital Acoustic Surveillance for Early Detection of Respiratory Disease Outbreaks

Completed Last updated 20 July 2022

What this trial tests

trial testing Hyfe cough tracker in Covid19 in 930 participants. Completed in 24 May 2022.

Timeline

11 November 2020

Primary endpoint
23 May 2022

24 May 2022

Quick facts

Lead sponsor	Clinica Universidad de Navarra, Universidad de Navarra
Status	Completed
Study type	OBSERVATIONAL
Enrollment	930
Start date	11 November 2020
Primary completion	23 May 2022
Estimated completion	24 May 2022
Sites	1 location across Spain

Drugs / interventions tested

Hyfe cough tracker

Conditions studied

Covid19 — all drugs for Covid19 →
Cough — all drugs for Cough →

Sponsor

Clinica Universidad de Navarra, Universidad de Navarra

Who can join

Adults 13 to 99, any sex, with Covid19 or Cough. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

An observational study to evaluate the accuracy of a digital cough monitoring tool to reflect the incidence of COVID-19 and other respiratory infections at the community level in the city of Pamplona, Spain.

Publications & conference data

6 peer-reviewed publications reference this trial (live from Europe PMC):

Longitudinal passive cough monitoring and its implications for detecting changes in clinical status.
Gabaldón-Figueira JC, Keen E, Rudd M, Orrilo V, et al · · 2022 · cited 27× · PMID 35586452 · DOI 10.1183/23120541.00001-2022
Acoustic surveillance of cough for detecting respiratory disease using artificial intelligence.
Gabaldón-Figueira JC, Keen E, Giménez G, Orrillo V, et al · · 2022 · cited 26× · PMID 35651361 · DOI 10.1183/23120541.00053-2022
Digital acoustic surveillance for early detection of respiratory disease outbreaks in Spain: a protocol for an observational study.
Gabaldon-Figueira JC, Brew J, Doré DH, Umashankar N, et al · · 2021 · cited 21× · PMID 34215614 · DOI 10.1136/bmjopen-2021-051278
Performance evaluation of the smartphone-based AI cough monitoring app - Hyfe Cough Tracker against solicited respiratory sounds.
Galvosas M, Gabaldón-Figueira JC, Keen EM, Orrillo V, et al · · 2022 · cited 5× · PMID 39931660 · DOI 10.12688/f1000research.122597.2
Performance evaluation of the smartphone-based AI cough monitoring app - Hyfe Cough Tracker against solicited respiratory sounds
Galvosas M, Gabaldón-Figueira JC, Keen EM, Orrillo V, et al · · 2023 · DOI 10.12688/f1000research.122597.2
Acoustic surveillance for respiratory diseases: a prospective analysis of cough trends using artificial intelligence.
Gabaldon-Figueira J, Keen E, Giménez G, Orrillo V, et al · · 2021 · DOI 10.21203/rs.3.rs-1161801/v1

Verify or expand the search:

Other recruiting trials for Covid19

Currently open trials in the same condition.

NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting

Other Clinica Universidad de Navarra, Universidad de Navarra trials

Trials by the same sponsor.

NCT07370571 — NO AXILLARY SURGERY IN EARLY BREAST CANCER (OXIGENATE) · not yet recruiting
NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). · NA · recruiting
NCT07447440 — Role of Pro-Resolving Lipid Mediators in Obesity-Associated Diseases · recruiting
NCT07191210 — Co-Designed Comprehensive Transition Programme for First-Line Nurse Managers · NA · not yet recruiting
NCT07132060 — MRI-guided Dose Intensification Program Locally Advanced Pancreatic Cancer · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04762693 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Clinica Universidad de Navarra, Universidad de Navarra
Last refreshed: 20 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04762693.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing